← Evidence map

ReviewBiomolecules2022

Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma.

Godfrey Chi-Fung Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

42 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35327550